August 20, 2025

Ithaca Energy posts $1.1bn H1 EBITDAX and boosts dividends

Ithaca Energy has reported a strong first half for 2025, with production averaging 123.6 kboe/d, adjusted EBITDAX exceeding $1.1 billion, and operating costs reduced to $17.5/boe. The company declared a $167 million interim dividend and confirmed plans to accelerate a further $133 million payment in December, reaffirming its full-year dividend target of $500 million...

Temple Bar Investment Trust delivers 19.9% share price return in H1 2025

Temple Bar Investment Trust has reported strong half-year results to 30 June 2025, with a 14.2% NAV total return and a 19.9% share price total return, outperforming the FTSE All-Share’s 9.1%. The Trust reduced its discount to NAV to 2% and declared an increased second interim dividend of 3.75p per share, reflecting its progressive dividend policy...

Ilika hits Stereax production milestone with Cirtec, Cavendish

Cavendish frames the update as a substantial de risking event. The commissioning phase in January 2025 was a vital precursor, and the latest qualification work represents the final technical validation before production...

LondonMetric raises quarterly dividend by 7% to 3.05p

LondonMetric has declared a 7% increase in its first quarterly interim dividend for FY 2025/26 to 3.05 pence per share, payable as a Property Income Distribution. The dividend will be paid on 8 October 2025, with an ex-dividend date of 28 August 2025 and a scrip alternative available...

Convatec Group Plc launches $300m share buyback programme

Convatec has announced a non-discretionary share buyback of up to $300 million to return surplus capital to shareholders. The programme, managed by UBS AG London Branch, will run until 31 December 2025 and aims to reduce the company’s share capital, with purchased shares either cancelled or held in treasury for employee plans...

HUTCHMED completes enrollment for phase III SANOVO lung cancer study

HUTCHMED has completed patient enrollment for its Phase III SANOVO trial evaluating ORPATHYS® (savolitinib) with TAGRISSO® (osimertinib) as a first-line treatment for certain EGFR-mutated, MET-overexpressed non-small cell lung cancer patients...

Cora Gold posts resource growth and advances Sanankoro development

Cora Gold has announced its unaudited interim results for H1 2025, highlighting a +1 million ounce Mineral Resource Estimate at the Sanankoro Gold Project in Mali, a 13% increase from 2022. The company advanced its Definitive Feasibility Study, raised £1.55m to fund development, and is engaging with authorities on a mining permit...
Search

Funds

August 20, 2025

Ithaca Energy posts $1.1bn H1 EBITDAX and boosts dividends

Ithaca Energy has reported a strong first half for 2025, with production averaging 123.6 kboe/d, adjusted EBITDAX exceeding $1.1 billion, and operating costs reduced to $17.5/boe. The company declared a $167 million interim dividend and confirmed plans to accelerate a further $133 million payment in December, reaffirming its full-year dividend target of $500 million...

Temple Bar Investment Trust delivers 19.9% share price return in H1 2025

Temple Bar Investment Trust has reported strong half-year results to 30 June 2025, with a 14.2% NAV total return and a 19.9% share price total return, outperforming the FTSE All-Share’s 9.1%. The Trust reduced its discount to NAV to 2% and declared an increased second interim dividend of 3.75p per share, reflecting its progressive dividend policy...

Ilika hits Stereax production milestone with Cirtec, Cavendish

Cavendish frames the update as a substantial de risking event. The commissioning phase in January 2025 was a vital precursor, and the latest qualification work represents the final technical validation before production...

LondonMetric raises quarterly dividend by 7% to 3.05p

LondonMetric has declared a 7% increase in its first quarterly interim dividend for FY 2025/26 to 3.05 pence per share, payable as a Property Income Distribution. The dividend will be paid on 8 October 2025, with an ex-dividend date of 28 August 2025 and a scrip alternative available...

Convatec Group Plc launches $300m share buyback programme

Convatec has announced a non-discretionary share buyback of up to $300 million to return surplus capital to shareholders. The programme, managed by UBS AG London Branch, will run until 31 December 2025 and aims to reduce the company’s share capital, with purchased shares either cancelled or held in treasury for employee plans...

HUTCHMED completes enrollment for phase III SANOVO lung cancer study

HUTCHMED has completed patient enrollment for its Phase III SANOVO trial evaluating ORPATHYS® (savolitinib) with TAGRISSO® (osimertinib) as a first-line treatment for certain EGFR-mutated, MET-overexpressed non-small cell lung cancer patients...

Cora Gold posts resource growth and advances Sanankoro development

Cora Gold has announced its unaudited interim results for H1 2025, highlighting a +1 million ounce Mineral Resource Estimate at the Sanankoro Gold Project in Mali, a 13% increase from 2022. The company advanced its Definitive Feasibility Study, raised £1.55m to fund development, and is engaging with authorities on a mining permit...
Search

Funds

August 20, 2025

FTSE 100

Funds